Sonire Therapeutics, a U.S.-based clinical-stage medical device company pioneering non-invasive ultrasound therapies for cancer treatment, today announced that Sonire Therapeutics KK, the firm’s Japan-based group company, has been selected for the New Energy and Industrial Technology Development Organization’s (NEDO) Deep-Tech Startups Support Program, which is one of Japan’s largest government-backed initiatives focused on accelerating the commercialization of breakthrough technologies.


